Publications
- IgA Nephropathy: Molecular Mechanisms of the Disease2013 | First Faculty of Medicine, Second Faculty of Medicine
- ACE - inhibitors and AT1R - antagonists are the first line medication for IgA nephropathy2008 | Second Faculty of Medicine
- IgA Nephropathy: A Clinical Overview2007 | Second Faculty of Medicine
- IgA nephropathy - the most common primary glomerulonephritis worldwide2006 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Immune globulin A, Tn antigen and IgA nephropathy +12003 | Second Faculty of Medicine
- IgA nepropathy2003 | Second Faculty of Medicine
- Pathogenetic Importance of Immunoglobulin A Glycosylation and Clinical Presentation2002 | Second Faculty of Medicine
- Galactose (Gal-) deficient IgA1-containing circulating immune complexes (CIC) from IgA nephropathy (IgAN) patients differentially stimulate or inhibit proliferation of mesangial cells (MC) and induce production of ctokines and chemokines.Publication without faculty affiliation
- Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors2022 | Second Faculty of Medicine
- Why should we salt with the mixture composed of 2/3 NaCl and of 1/3 NaHCO3 in renal patients?2021 | First Faculty of Medicine, Second Faculty of Medicine
Loading network view...